Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer. [electronic resource]
Producer: 20110411Description: 557-64 p. digitalISSN:- 1349-7006
- Animals
- Antineoplastic Agents, Hormonal -- pharmacology
- Cell Line, Tumor
- Chromones -- pharmacology
- Drug Resistance, Neoplasm
- Endometrial Neoplasms -- drug therapy
- Female
- Humans
- Medroxyprogesterone Acetate -- pharmacology
- Mice
- Mice, Inbred BALB C
- Morpholines -- pharmacology
- Phosphatidylinositol 3-Kinases -- physiology
- Phosphoinositide-3 Kinase Inhibitors
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Receptors, Progesterone -- analysis
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.